← back to search

Arthur Schwartzbard

New York University · US
Area of research
Surgery · Endocrinology, Diabetes and Metabolism
Research interest
Research focused on Diabetes mellitus and Type 2 diabetes, with related work in Glycemic, Myocardial infarction, Dyslipidemia. Notable publications include 'Primary Prevention of Cardiovascular Disease in Diabetes Mellitus', 'Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials', and 'Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists'.
h-index
citations
752
works
10
NIH funding
primary concept
email

Recent publications

Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists
Journal of the American College of Cardiology 2020cited by 94position: middledoi
A Case Report: Euglycemic Diabetic Ketoacidosis Presenting as Chest Pain in a Patient on a Low Carbohydrate Diet
Current Diabetes Reviews 2020cited by 20position: middledoi
The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction
Journal of the American College of Cardiology 2018cited by 94position: lastdoi
Towards more specific treatment for diabetic dyslipidemia
Current Opinion in Lipidology 2018cited by 22position: lastdoi
Primary Prevention of Cardiovascular Disease in Diabetes Mellitus
Journal of the American College of Cardiology 2017cited by 211position: middledoi
Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials
The American Journal of Medicine 2017cited by 179position: middledoi
Cardiovascular disease leads to a new algorithm for diabetes treatment
Journal of clinical lipidology 2017cited by 15position: lastdoi
Diabetes mellitus is a coronary heart disease risk equivalent for peripheral vascular disease
American Heart Journal 2016cited by 57position: middledoi
Diabetes and Vascular Disease in Different Arterial Territories
Diabetes Care 2014cited by 43position: middledoi
A Current Approach to Statin Intolerance
Clinical Pharmacology & Therapeutics 2014cited by 17position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Howard Weintraub · NYU Langone Health7 papers (2014–2018)Jonathan Newman · New York University6 papers (2016–2020)Jeffrey S. Berger · JDSU (United States)4 papers (2014–2018)Ira J. Goldberg · NYU Langone Health3 papers (2017–2020)Yu Guo · New York University2 papers (2014–2016)Eugenia Gianos · New York University2 papers (2014–2017)Caron Rockman · New York University2 papers (2014–2016)Mark A. Adelman · New York University2 papers (2014–2016)Valentina Aybar Rodríguez · New York University2 papers (2017–2018)Judy Zhong · NYU Langone Health1 papers (2016–2016)Edward A. Fisher · Institute for Biomedical Engineering1 papers (2014–2014)Matthew Weiss · New York University1 papers (2017–2017)Tanya Wilcox · New York University1 papers (2020–2020) · 1 papers (2020–2020) · 1 papers (2020–2020)Thomas S. Riles · New York University1 papers (2014–2014)Franz H. Messerli · University of Bern1 papers (2017–2017)Christophe De Block · University of Antwerp1 papers (2020–2020)Anish Vani · New York University1 papers (2018–2018)Bora Toklu · New York University1 papers (2017–2017)